FORM 3
        
UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

INITIAL STATEMENT OF BENEFICIAL OWNERSHIP OF SECURITIES

OMB APPROVAL
OMB Number: 3235-0104
Estimated average burden
hours per response...
0.5
                      
Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934, Section 17(a) of the Public Utility Holding Company Act of 1935 or Section 30(h) of the Investment Company Act of 1940
                      

1. Name and Address of Reporting Person *

Cormier Barbara

2. Date of Event Requiring Statement (MM/DD/YYYY)
3/8/2012 

3. Issuer Name and Ticker or Trading Symbol

BioScrip, Inc. [BIOS]

(Last)        (First)        (Middle)

100 CLEARBROOK ROAD

4. Relationship of Reporting Person(s) to Issuer (Check all applicable)

_____ Director                            _____ 10% Owner
___ X ___ Officer (give title below)          _____ Other (specify below)
Compliance Officer /

(Street)

ELMSFORD, NY 10014       

(City)              (State)              (Zip)
5. If Amendment, Date Original Filed (MM/DD/YYYY)

 

6. Individual or Joint/Group Filing (Check Applicable Line)

_ X _ Form filed by One Reporting Person
___ Form filed by More than One Reporting Person


Table I - Non-Derivative Securities Beneficially Owned
1.Title of Security
(Instr. 4)
2. Amount of Securities Beneficially Owned
(Instr. 4)
3. Ownership Form: Direct (D) or Indirect (I)
(Instr. 5)
4. Nature of Indirect Beneficial Ownership
(Instr. 5)
Common Stock, $.0001 Par Value   12246   D    

Table II - Derivative Securities Beneficially Owned ( e.g. , puts, calls, warrants, options, convertible securities)
1. Title of Derivate Security
(Instr. 4)
2. Date Exercisable and Expiration Date
(MM/DD/YYYY)
3. Title and Amount of Securities Underlying Derivative Security
(Instr. 4)
4. Conversion or Exercise Price of Derivative Security 5. Ownership Form of Derivative Security: Direct (D) or Indirect (I)
(Instr. 5)
6. Nature of Indirect Beneficial Ownership
(Instr. 5)
Date Exercisable Expiration Date Title Amount or Number of Shares
Employee Stock Option   7/1/2006   7/1/2015   Common Stock, $.0001 Par Value   460   $6.00   D    
Employee Stock Option   11/1/2007   11/1/2016   Common Stock, $.0001 Par Value   12000   $2.47   D    
Employee Stock Option   4/29/2009   4/29/2018   Common Stock, $.0001 Par Value   19687   $6.52   D    
Employee Stock Option   4/28/2010   (1) 4/28/2019   Common Stock, $.0001 Par Value   20000   $2.73   D    
Employee Stock Option   6/16/2011   (1) 6/16/2020   Common Stock, $.0001 Par Value   15000   $6.65   D    
Employee Stock Option   4/26/2012   (1) 4/26/2021   Common Stock, $.0001 Par Value   50000   $4.42   D    

Explanation of Responses:
( 1)  Vests and becomes exercisable in three equal annual installments commencing on the first anniversary of the date of grant.

Reporting Owners
Reporting Owner Name / Address
Relationships
Director 10% Owner Officer Other
Cormier Barbara
100 CLEARBROOK ROAD
ELMSFORD, NY 10014


Compliance Officer

Signatures
/s/ Barbara Cormier 4/3/2012
** Signature of Reporting Person Date


Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 5(b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations. See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB control number.
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Sept 2024 à Oct 2024 Plus de graphiques de la Bourse BioPlus Acquisition
BioPlus Acquisition (NASDAQ:BIOS)
Graphique Historique de l'Action
De Oct 2023 à Oct 2024 Plus de graphiques de la Bourse BioPlus Acquisition